Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability of BI 671800 Formulations
NCT02222233Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2010
- Primary completion
- Mar 2010
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of BI-671800 in asthma (5 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Area under the concentration-time curve from 0 to infinity up to 24 hours. Started Jan 2010; status: completed.
02
Drugs
BI-671800
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02222233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02222233.